Publications by authors named "Martin Forster"

Claim this Profile
I
International, Multi-Institutional Evaluation of Practice Patterns and Outcomes for Recurrent and Metastatic Sinonasal Undifferentiated Carcinoma.
Anirudh Saraswathula, Mohammed N Ullah, Jacklyn Liu, Yoko Takahashi, Arushi Mahajan, Martin D Forster

J Neurol Surg B Skull Base· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Alessio Cortellini, Valentina Santo, Leonardo Brunetti, Edoardo Garbo, David J Pinato, Martin Forster

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial.
Magnus T Dillon, Emmanuel C Patin, Kabir Mohammed, Jeane Guevara, Simon A Smith, Martin D Forster

Nat Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parent training tailored for parents with ADHD: a randomized controlled trial.
Therese Lindström, Sofia Buddgård, Lena Westholm, Martin Forster, Sven Bölte

BMC Psychiatry· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity: A Real-World UK Multi-Centre Study.
Umair Mahmood, Eleni Josephides, Meenali Chitnis, Michael Skwarski, Spyridon Gennatas, Martin Forster

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials for patients with salivary gland cancers: A systematic review of worldwide registers and an evaluation of current challenges.
Pablo Jiménez-Labaig, Luigi Lorini, Cristina Gurizzan, Emma Kinloch, Sarah Burton, Martin D Forster

Crit Rev Oncol Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Squamous Cell Carcinoma of the Mastoid Cavity in a Patient with Lynch Syndrome - A New Lynch Syndrome-Associated Cancer and Its Clinical Implications.
Jacklyn Liu, Liam Sutton, Umar Rehman, Manuel Rodriguez-Justo, Amrita Jay, Martin Forster

Eur Arch Otorhinolaryngol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxygen-Enhanced R2* Weighted MRI and Diffusion Weighted MRI of Head and Neck Squamous Cell Cancer Lymph Nodes in Prediction of 2-Year Outcome Following Chemoradiotherapy.
Harbir Singh Sidhu, David Price, Tim Beale, Simon Morley, Sola Adeleke, Martin Forster

Cancers (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements.
Seshiru Nakazawa, Federica Pecci, Igor Odintsov, Dimitris Gazgalis, Felix H Gottlieb, Martin D Forster

Cancer Discov· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value-adaptive clinical trial designs for efficient delivery of publicly funded trials - a discussion of methods, case studies, opportunities and challenges.
Laura Flight, Alan Brennan, Stephen E Chick, Martin Forster, Steven Julious

BMC Med Res Methodol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.
Maise Al Bakir, James L Reading, Samuel Gamble, Rachel Rosenthal, Imran Uddin, Martin D Forster

Nature· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parents' experiences of parent training after reported child abuse: A qualitative study.
Livia van Leuven, Maja Västhagen, Martin Forster, Lene Lindberg

Child Abuse Negl· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expression.
Jacklyn Liu, Helen Bewicke-Copley, Shruti Patel, Oscar Emanuel, Nicholas Counsell, Martin D Forster

Clin Transl Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.
Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio, Edoardo Garbo, David J Pinato, Martin Forster

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trial.
Siow Ming Lee, Madeleine Hewish, Samreen Ahmed, Dionysis Papadatos-Pastos, Eleni Karapanagiotou, Martin Forster

Eur J Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of heart failure medical therapy before and after a cancer diagnosis: A longitudinal study.
Chengsheng Ju, Wallis C Y Lau, Charlotte Manisty, Pinkie Chambers, Ruth Brauer, Martin D Forster

ESC Heart Fail· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and predictive factors for positive non-sentinel lymph nodes in completion neck dissection following a positive sentinel node biopsy in early oral cancer.
Searan Karamchandani, Axel Sahovaler, Elizabeth Crosbie-Jones, Mark McGurk, Selvam Thavaraj, Martin D Forster

Oral Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entrectinib-Induced Myocarditis and Acute Heart Failure Responding to Steroid Treatment: A Case Report.
Mehraab N Majeed, Subramanian Venkatesan, Dionysis Papadatos-Pastos, Tanya Ahmad, Martin Forster

JTO Clin Res Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer.
Luke Steventon, Kenneth K C Man, Shibani Nicum, Rowan E Miller, Shira Peleg Hasson, Martin D Forster

Oncologist· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eftilagimod Alpha (a Soluble LAG-3 Protein) Combined With Pembrolizumab in Second-Line Metastatic NSCLC Refractory to Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1-Based Therapy: Final Results from a Phase 2 Study.
Matthew G Krebs, Martin Forster, Margarita Majem, Julio Peguero, Wade Iams

JTO Clin Res Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective cohort study.
Luke Steventon, Emma Kipps, Kenneth Kc Man, Rebecca Roylance, Martin D Forster

Eur J Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation.
David M Waterhouse, Sacha Rothschild, Christophe Dooms, Bertrand Mennecier, Farastuk Bozorgmehr, Martin D Forster

Lung Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The performance of a Bayesian value-based sequential clinical trial design in the presence of an equivocal cost-effectiveness signal: evidence from the HERO trial.
Charlie Welch, Martin Forster, Sarah Ronaldson, Ada Keding, Belen Corbacho-Martín

BMC Med Res Methodol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of high-resolution computed tomography and immunological bronchoalveolar lavage in interstitial lung disease at the onset of inflammatory rheumatic diseases: implications for diagnosis and therapeutic strategies.
Tobias Hoffmann, Ulf Teichgräber, Martin Förster, Peter Oelzner, Claus Kroegel

Arthritis Res Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancer.
Anthony Kong, Amanda J Kirkham, Joshua S Savage, Rhys Mant, Siân Lax, Martin D Forster

BJC Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis